Menu

Press Releases

CitraVet™ offers a better way to manage Urolithiasis

CitraVet, the newest addition to the PRN Pharmacal product lineup, offers a better way to manage Urolithiasis (recurring urinary stones) and overall urinary health in at-risk patients. Urolithiasis is a common problem in dogs and cats, especially male dogs approaching middle age. The recurrence of uroliths in cats is up to 70% and in dogs is 35%. As surgery is often the only treatment option, urinary health management should be the first line of defense.

CitraVet, liver-flavored chewable tablets contain 675 mg of potassium citrate and is formulated for both dogs and cats. CitraVet can be used alone or with a maintenance program to support overall urinary health.

Managing at-risk patient health is becoming more important in this economy. Pet owners struggle to pay high costs of treatments and surgery, CitraVet complements our CranMate® product launched earlier this year." stated PRN Pharmacal Vice-President of Sales, Gary Cushing. "Our products offer veterinarians and pet owners cost-effective solutions for total health management.

CitraVet is manufactured by Pegasus Laboratories, Inc. under the PRN Pharmacal brand and is available nation-wide through veterinary distributors. Pegasus has over 30 years of service to the veterinary pharmaceutical industry with a production facility in Pensacola, Florida. For more information on CranVet, visit prnpharmacal.com/cranvet or call 1-800-874-9764.